Essentially what it does is ensure that CAMR is consistent with Bill C-393 in terms of the drugs and the countries. That's what will happen by these consequential acts.
Although TRIPS and WTO didn't require that list, it was built in during the original CAMR, for a number of different reasons. I'm agreeing to them even though I don't believe it's necessary, but at the same time, it is what was done before and there has been some concern expressed about that, so that will allow the current Bill C-393 to be consistent with the drugs and the countries and the language from the previous bill.